{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:17:28Z","timestamp":1787771848678,"version":"build-2784847793"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>For the management of hemolytic disease of the fetus and newborn (HDFN), it is important to detect unexpected red cell antibody in pregnant women. We assessed the prevalence of unexpected red cell antibodies in consecutive pregnant women attending antenatal clinic (ANC). More importantly, cases with unexpected antibody causing severe anemia were followed-up for intervention (Intra-uterine transfusion {IUT}) and outcome of pregnancy (still-birth\/live-healthy).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>AIMS AND OBJECTIVES:<\/jats:title>\n                    <jats:p>The study was conducted with an objective to find the prevalence of unexpected RBC antibodies in pregnant women, their specificity and to do the follow-up for IUT and outcome of pregnancy (still-birth, live-birth) in antibody positive women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>This was a prospective study from January 2021 to May 2022 at two tertiary care centres. All antenatal samples received by the laboratory were screened for unexpected red cell antibody. Whenever antibody screen was positive, antibody identification was performed. Patients, positive for unexpected antibody and anemia were followed up for any transfusion-based intervention and outcome of pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 539 consecutive samples were worked up and among these, 10 samples (1.85%) were found to be antibody positive. The antibodies identified were Anti-D (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =6), anti-Le\n                      <jats:sup>b<\/jats:sup>\n                      (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =1), anti-M (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =1), anti-C (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =1) and anti-E (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =1).The prevalence of unexpected antibodies in Rh positive and Rh negative pregnant women was 0.83% and 10.9% respectively. Follow-up was done for all 10 cases with unexpected antibody and anemia was monitored by MCA PSV (middle cerebral artery peak systolic velocity).Two women developed severe anemia thus requiring single intrauterine transfusion (at 26 weeks and 28 weeks respectively) each, for correction of anemia. In both these cases, healthy male child was delivered. At 3-month follow-up both children were alive and healthy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The study found prevalence of unexpected RBC antibodies in pregnant women as 1.85%. The study also underlined importance of transfusion-based interventions contributing to successful outcome in couple of cases with severe anemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_46_23","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T01:01:26Z","timestamp":1707267686000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of unexpected red blood cell antibodies in pregnant women and follow-up of pregnancy outcome in pregnant women treated with intra-uterine transfusion"],"prefix":"10.4103","volume":"18","author":[{"given":"Sunil","family":"Golia","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity, Gurugram, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem Kumar","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity, Gurugram, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geet","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity, Gurugram, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Khetrapal","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Artemis Hospital, Gurugram, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep Kumar","family":"Tyagi","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Artemis Hospital, Gurugram, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetna","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Cloud Nine Hospital, Gurugram, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity, Gurugram, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samruddhi","family":"Pawar","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity, Gurugram, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/asheducation-2016.1.446","article-title":"Understanding red blood cell alloimmunization triggers","volume":"2016","author":"Hendrickson","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12288-015-0593-3","article-title":"Prevalence, specificity and titration of red cell alloantibodies in multiparous antenatal females at a tertiary care Centre from North India","volume":"32","author":"Sidhu","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/IJPM.IJPM_737_19","article-title":"Frequency and clinical significance of red cell antibodies in pregnancy \u2013A prospective study from India","volume":"63","author":"Das","year":"2020","journal-title":"Indian J Pathol Microbiol"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s13224-017-0984-5","article-title":"Frequency of red cell alloantibodies in pregnant females of Navsari district:An experience that favours inclusion of screening for irregular erythrocyte antibody in routine antenatal testing profile","volume":"68","author":"Kahar","year":"2018","journal-title":"J Obstet Gynaecol India"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajog.2015.01.059","article-title":"Society for Maternal-Fetal Medicine (SMFM) clinical guideline #8:The fetus at risk for anemia \u2013Diagnosis and management","volume":"212","author":"Mari","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20240830","first-page":"25","article-title":"Obstetric management in Rh alloimmunizated pregnancy","volume":"3","author":"Cacciatore","year":"2009","journal-title":"J Prenat Med"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"22","DOI":"10.15380\/2277-5706.JCSR.14.041","article-title":"Prevalence of \u201cunexpected antibodies\u201din the antenatal women attending the Government Maternity Hospital, Tirupati","volume":"4","author":"Suresh","year":"2015","journal-title":"J Clin and Sci Res"},{"key":"R9-20240830","first-page":"388","article-title":"The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi","volume":"9","author":"Pahuja","year":"2011","journal-title":"Blood Transfus"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0973-6247.137452","article-title":"ABO and Rh (D) group distribution and gene frequency;the first multicentric study in India","volume":"8","author":"Agrawal","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tme.12099","article-title":"Anti-D prophylaxis:Past, present and future","volume":"24","author":"de Haas","year":"2014","journal-title":"Transfus Med"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","article-title":"Thirty-five years of Rh prophylaxis","volume":"43","author":"Bowman","year":"2003","journal-title":"Transfusion"},{"key":"R13-20240830","first-page":"68","article-title":"Red cell alloimmunization among antenatal women attending a tertiary care hospital in south India","volume":"138","author":"Varghese","year":"2013","journal-title":"Indian J Med Res"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/17474086.2017.1305265","article-title":"Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn \u2013Review on current management and outcome","volume":"10","author":"Zwiers","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/aogs.12590","article-title":"Diagnosis and treatment of severe hemolytic disease of the fetus and newborn:A 10-year nationwide retrospective study","volume":"94","author":"Sainio","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R16-20240830","first-page":"129","article-title":"Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization:14 years experience in Leuven","volume":"7","author":"Pasman","year":"2015","journal-title":"Facts Views Vis Obgyn"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00404-015-3915-7","article-title":"Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization","volume":"293","author":"Deka","year":"2016","journal-title":"Arch Gynecol Obstet"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_46_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:17:38Z","timestamp":1787768258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_46_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_46_23","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-02-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}